The committee voted 16 to 1 that available data support the safety and effectiveness of Paxlovid for treating mild to moderate COVID-19 in adult patients at high risk for progression to severe illness.
Epinephrine injection is indicated for emergency treatment of certain allergic reactions, as well as to increase mean arterial blood pressure in adults with hypotension associated with septic shock.
Through an agreement between the Medicines Patent Pool and ViiV Healthcare, the three generic manufacturers can develop, manufacture and supply generic versions of cabotegravir LA for PrEP in 90 countries.